Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2025-12-25 @ 9:44 PM
NCT ID:
NCT00121251
Group ID:
EG000
Title:
Sorafenib + Gemcitabine + Capecitabine
Description:
Patients receive sorafenib\* PO BID on days 1-21, gemcitabine IV over 30 minutes on days 1 and 8, and capecitabine PO BID on days 1-14. Treatment repeats every 21 days for at least 3 courses in the absence of unacceptable toxicity or disease progression.
Capecitabine: Given PO
Gemcitabine Hydrochloride: Given IV
Sorafenib Tosylate: Given PO
Deaths Number Affected:
11
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
17
Other Number Affected:
5
Other Number At Risk:
17
Study:
NCT00121251
Results Section:
NCT00121251
Adverse Events Module:
NCT00121251